Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Prevention
Prophylactic endocrine treatment is not recommended outside clinical trial setting
January 26th, 2006
Prophylactic endocrine treatment is not recommended for high-risk women outside of the clinical trial setting. "Epidemiological, experimental and clinical data strongly support the possibility that breast cancer can be prevented by using anti-estrogenic interventions in healthy women," according to a recent article in the Annals of Oncology. "Four trials involving over 25,000 women have so far been reported using tamoxifen 20 mg/day or placebo in healthy women to chemo-prevent breast cancer, and several trials utilizing raloxifene or aromatase inhibitors are underway." H. Gogas and colleagues wrote, "Interim analyses of the Royal Marsden...
Source: Women's Health Weekly (2006-01-26)
|
